China Pharma Holdings (CPHI) Work In Process (2017 - 2024)
China Pharma Holdings (CPHI) posted Work In Process of $334430.0 for Q3 2024, up 283.05% on a QoQ basis from $87308.0 in Q2 2024, and down 50.59% year-over-year from $676885.0 in Q4 2023.
China Pharma Holdings (CPHI) Work In Process (2017 - 2024) Analysis & Trends
China Pharma Holdings' Work In Process history runs 8 years deep, the most recent figure standing at $334430.0 for Q3 2024.
- Quarterly Work In Process fell 50.59% year-over-year to $334430.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $334430.0 (down 50.59% YoY) and the FY2023 annual result came in at $413597.0, down 25.77% from the prior year.
- Work In Process was $334430.0 for Q3 2024 at China Pharma Holdings, up from $87308.0 in the prior quarter.
- Across five years, Work In Process topped out at $676885.0 in Q3 2023 and bottomed at $87308.0 in Q2 2024.
- A 5-year average of $431457.2 and a median of $423493.0 in 2020 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2020 — Work In Process surged 110.99% — and 2024, when it sank 76.07%.
- China Pharma Holdings' Work In Process stood at $662999.0 in 2020, then decreased by 15.97% to $557146.0 in 2021, then changed by 0.0% to $557146.0 in 2022, then dropped by 25.77% to $413597.0 in 2023, then slipped by 19.14% to $334430.0 in 2024.
- Business Quant data shows CPHI's Work In Process at $334430.0 in Q3 2024, $87308.0 in Q2 2024, and $242726.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 334,430.00 |
| Jun 30, 2024 | 87,308.00 |
| Mar 31, 2024 | 242,726.00 |
| Dec 31, 2023 | 413,597.00 |
| Sep 30, 2023 | 676,885.00 |
| Jun 30, 2023 | 364,913.00 |
| Mar 31, 2023 | 319,059.00 |
| Dec 31, 2022 | 557,146.00 |
| Sep 30, 2022 | 615,020.00 |
| Jun 30, 2022 | 356,702.00 |
| Dec 31, 2021 | 557,146.00 |
| Sep 30, 2021 | 442,022.00 |
| Jun 30, 2021 | 461,293.00 |
| Mar 31, 2021 | 341,269.00 |
| Dec 31, 2020 | 662,999.00 |
| Sep 30, 2020 | 433,389.00 |
| Jun 30, 2020 | 644,174.00 |
| Mar 31, 2020 | 256,151.00 |
| Dec 31, 2019 | 314,231.00 |
| Sep 30, 2019 | 382,900.00 |